BEDFORD, Mass., March 26 /PRNewswire/ -- Toxikon Corporation will host their second annual medical device and testing seminar April 17 at their headquarters in Bedford, Massachusetts.
As safety-testing guidelines continue to be updated and revised, medical device manufacturers must address the testing requirements appropriate for their product. With new innovations and applications in development, testing guidelines can be vague, requiring device manufacturers to implement timely and cost-effective testing programs.
The seminar will review considerations in ISO and MHLW biocompatibility testing, as well as recent trends in extractables/leachable and microbiological evaluations.
Toxikon employees scheduled to speak at this popular event include Laurence Lister, Director of Biocompatibility; Dr. Stephen Doherty, Study Director for Chemistry; and Dr. Sharon Malia, Study Director for Microbiology. Workshops will immediately follow the three presentations.
Registration cost is $465 per person and is open to medical device industry professionals, particularly those involved in research and development, quality assurance, regulatory affairs and design engineering. Breakfast and lunch is included.
Due to popular demand, the event is limited to no more than two representatives per company. Registration is on a first-come, first-served basis and will be limited to 40 people.
For more information, contact Joann Hoxha at (800) 458-4141 or e-mail firstname.lastname@example.org.
Toxikon Corporation is an ISO 17025-certified global Contract Research Organization (CRO) that conducts compliance studies for the medical device and biopharmaceutical industries, as well as academic research centers.
|SOURCE Toxikon Corporation|
Copyright©2008 PR Newswire.
All rights reserved